PEVAR CASE STUDY:
Procedural Efficiency and Cost
Benefit of Percutaneous EVAR
“ATTENDING THE ENDOLOGIX PEVAR COURSE IS THE BEST THING I DID FOR MY TRAINING.”
The key to mastering this technique is all about the nuances and details you may not get from the fellowship training. The PEVAR
course instructor had hundreds of cases under his belt, and learning
from someone with so much experience made all the difference.
“WITH BILATERAL PEVAR I SAVE
34-45 MINUTES PER CASE”
Bilateral PEVAR with the AFX® System’s 9 F contralateral introducer
eliminates a number of time consuming steps: opening equipment,
femoral artery exposure, closing the artery. After attending the training, I was able to save 34-45 minutes per case. You could be
saving anywhere from 15 minutes to one hour, depending on your
experience level, patient body habitus, and whether they had prior
access on that area.1
“OUR PRACTICE SAVES ABOUT $2,400 PER
PROCEDURE BY ADOPTING PEVAR”
In our practice, the cost savings from reduced OR time and on suturerelated devices far outweigh the incremental costs. We are
typically seeing a $2,400 net cost savings per procedure (Figure 1), not even taking into account the additional 0.5 day savings in average length of stay as reported in the PEVAR trial.1
Alok K. Gupta, MD
Assistant Professor Indiana University
Education:
St. George’s University
Internship and residency at the University at Buffalo, SUNY; Indiana University
Figure 1. Cost benefit of PEVAR in our practice
INCREMENTAL COST OF PEVAR
Cost of Closure Devices
Patients return for follow-up visits feeling great. Seeing only a small
puncture in the groin makes a world of difference in terms of their
perception of the procedure severity.
2
Cost of ProGlide device $
199
Cost of Ultrasound $
Resources (sterile sleeve)
10
TOTAL COST OF PEVAR
“INCISIONLESS PROCEDURE MAKES A WORLD
OF DIFFERENCE FOR MY PATIENTS” 2
$ 398
# ProGlide® devices
for ipsi hole closure3
$ 408
PEVAR SAVINGS
Reduced OR Time4
$2,278
# Minutes saved
Cost per minute
Other Savings
34
$
67
$ 551
Cost of sutures
$
68
Cost of sterile
cutdown tray use
$
433
Oral narcotics
$
50
TOTAL SAVINGS
OF PEVAR
$2,829
COST BENEFIT OF PEVAR $2,421
Enhance Your Practice with
Percutaneous EVAR
The U.S. FDA approval of the Endologix AFX® Endovascular AAA System and associated labeling served as the basis for development
of the first formal training program for PEVAR, proctored by the
leading experts in the field. The program is designed to provide the Endovascular Specialist with practical techniques to confidently
implement PEVAR in their daily practice.
ENDOLOGIX PROGRAM CURRICULUM
• Interactive learning with renowned, certified faculty
• Didactic training including patient selection, best practices and troubleshooting techniques
• Hands on practice with the AFX® Endovascular AAA System and Perclose ProGlide® Suture-Mediated Closure Device
• Live case observation
• Customizable tools and resources for successful PEVAR practice management
THE ENDOLOGIX PEVAR PHYSICIAN EDUCATION PROGRAM IS AVAILABLE AT SELECT STATE-OF-
THE-ART FACILITIES NATIONWIDE.
Call your local Endologix representative for details or scan here to register in the PEVAR Physician Education Program.
www.endologix.com – 949.595.7200
1. Individual time and costs savings will vary.
2. Incisionless procedure is the approach at this center; approaches may vary across users.
3. Prior to adopting bilateral PEVAR, we have routinely utilized 1 ProGlide device for contralateral closure with AFX 9F introducer.
4. PEVAR trial demonstrated average 34 minutes saved.
INDICATIONS FOR USE: The Endologix AFX/AFX2 Endovascular AAA Systems are indicated for treatment of patients with abdominal aortic aneurysms having the vascular morphology suitable for endovascular repair using a surgical vascular access technique or a bilateral percutaneous technique; adequate iliac/femoral access compatible with the required delivery systems (diameter ≥ 6.5mm); a non-aneurysmal aortic neck between the renal arteries and the aneurysm: with length of ≥ 15mm, diameter ≥ 18 to ≤ 32mm and neck angle of 60° to the body of the aneurysm; aortic length ≥ 1.0cm longer than the body portion of the chosen bifurcated model; common iliac
artery distal fixation site with length ≥ 15mm, diameter of ≥ 10 to ≤ 23mm, and with ability to preserve at least one hypogastric artery; and with an iliac angle of 90° to the
aortic bifurcation. Extension stent grafts must have the ability to overlap the bifurcated stent graft by at least 30 to 40mm proximally and at least 15 to 20mm distally.
CONTRAINDICATIONS: The Endologix AFX/AFX2 Endovascular AAA Systems are contraindicated for use in patents who have a condition that threatens to infect the
graft and in patients with sensitivities or allergies to the device materials.
Refer to the Instructions for Use for more information concerning Indications, Contraindications, Warnings and Precautions, and Adverse Events.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
NOTE: The AFX® Endovascular AAA System and associated components are not available in all countries or regions. Please contact your Endologix representative for details regarding product availability.
CE marked. Please refer to current product instructions for use.
Endologix and AFX are registered trademarks of Endologix, Inc.
All other trademarks are the property of their respective owners.
©2016 Endologix, Inc. All rights reserved. MM0713 Rev 02